UTHR vs VREX
United Therapeutics vs Varex Imaging Corporation — AI-powered side-by-side comparison
UTHR
United Therapeutics
72
Buy
VS
VREX
Varex Imaging Corporation
57
Watch
| Metric | UTHR | VREX |
|---|
| AI Score |
72
|
57
|
| Price |
$514.89
|
$18.60
|
| P/E Ratio |
17.05×
|
35.39×
|
| ROE |
18.8%
|
-14.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
86.1%
|
34.3%
|
| Debt / Equity |
0.00×
|
0.75×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
52.2
|
96.6
|
| Beta |
0.564
|
0.877
|
| Expected Upside |
+6.4%
|
—
|
AI Committee View
Current Innellis committee reasoning for UTHR versus VREX.
UTHR leads by 15 points.
UTHR scores 72/100 (Buy) versus VREX at 57/100 (Watch).
UTHR Committee View
80% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Lower Highs / Lower Lows structure confirms bearish price action.
- Risk/reward is unfavorable: 13.5% downside vs 6.4% upside.
VREX Committee View
50% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 77.9% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- RSI at 97 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
- Weekly RSI at 89 -- overbought on the larger timeframe too — Technical